Powered by

Powered by Portfolio Grader

Abiomed Inc (ABMD)

322.52 2.80 (0.88%) 10:05 EST
ABMD Stock Quote Delayed 15 Minutes

  • ABMD Stock Chart

  • Historical ABMD Prices

  
Dividend & Yield:       N/A (N/A)
P/E:       131.64
Market Cap:       14.34B
EPS:       2.45
Volume:       40,778
Day's Range:       312.03 - 323.68
52wk Range:       187.41 - 459.75
Quotes delayed at least 20 mins.
Historical Data for ABMD
Month:  Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
Year:  2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Range:  1 Month 3 Month 1 Year
Date Open High Low Volume Close Change %
12/13/18 332.42 338.21 317.26 438,037 319.72 -10.97   -3.32%
12/12/18 335.00 341.09 330.32 376,924 330.69 2.56   0.78%
12/11/18 330.00 330.80 322.60 391,828 328.13 4.47   1.38%
12/10/18 317.90 326.79 312.46 447,764 323.66 6.14   1.93%
12/07/18 331.56 333.00 315.05 469,000 317.52 -15.46   -4.64%
12/06/18 318.00 333.26 310.58 501,107 332.98 5.80   1.77%
12/04/18 340.83 343.20 321.90 587,700 327.18 -16.27   -4.74%
12/03/18 339.62 344.99 333.21 571,745 343.45 10.77   3.24%
11/30/18 334.36 335.98 329.04 522,900 332.68 0.69   0.21%
11/29/18 331.65 335.42 327.00 520,282 331.99 -3.23   -0.96%
11/28/18 316.64 335.99 316.45 709,302 335.22 21.27   6.77%
11/27/18 309.30 318.52 304.56 1,090,199 313.95 2.80   0.90%
11/26/18 301.40 312.27 295.20 724,516 311.15 11.74   3.92%
11/23/18 299.88 305.70 298.25 224,600 299.41 -2.19   -0.73%
11/21/18 0.00 301.60 301.60 0 301.60 -0.69   -0.23%
11/20/18 288.92 307.92 280.83 963,799 302.29 2.46   0.82%
11/19/18 316.03 316.32 293.73 950,857 299.83 -19.95   -6.24%
11/16/18 318.04 332.15 315.38 752,800 319.78 -1.00   -0.31%
11/15/18 310.58 324.27 301.12 931,334 320.78 8.22   2.63%
11/14/18 333.30 335.16 309.83 1,160,548 312.56 -18.07   -5.47%
11/13/18 342.40 351.74 329.30 784,614 330.63 -7.23   -2.14%
11/12/18 388.99 388.99 330.01 1,692,893 337.86 -67.31   -16.61%
11/09/18 413.32 413.32 395.64 527,300 405.17 -8.68   -2.10%
11/08/18 409.80 420.18 404.01 436,239 413.85 1.75   0.42%
11/07/18 410.00 427.70 402.00 815,654 412.10 22.25   5.71%
11/06/18 392.78 399.58 381.84 442,598 389.85 -3.06   -0.78%
11/05/18 385.85 395.24 379.51 707,486 392.91 8.78   2.29%
11/02/18 390.00 399.88 376.12 765,300 384.13 7.19   1.91%
11/01/18 357.00 378.37 342.00 1,482,052 376.94 35.74   10.47%
10/31/18 338.00 352.45 333.88 897,698 341.20 9.98   3.01%
10/30/18 320.15 333.67 315.34 602,824 331.22 11.19   3.50%
10/29/18 331.39 339.69 313.40 730,090 320.03 -10.32   -3.12%
10/26/18 320.10 337.52 317.56 753,300 330.35 -2.77   -0.83%
10/25/18 352.00 352.00 317.00 1,416,132 333.12 -19.59   -5.55%
10/24/18 369.48 376.80 352.00 497,901 352.71 -17.33   -4.68%
10/23/18 358.89 373.85 350.25 492,533 370.04 3.84   1.05%
10/22/18 363.02 368.69 355.61 504,893 366.20 3.78   1.04%
10/19/18 388.41 391.70 360.63 850,400 362.42 -24.21   -6.26%
10/18/18 389.47 389.96 380.05 462,805 386.63 -3.16   -0.81%
10/17/18 391.57 391.57 380.05 355,505 389.79 2.91   0.75%
10/16/18 376.28 388.11 374.74 460,620 386.88 14.80   3.98%
10/15/18 383.78 387.97 367.24 674,031 372.08 -12.70   -3.30%
10/12/18 381.57 396.19 374.26 989,200 384.78 17.24   4.69%
10/11/18 372.00 383.88 363.63 815,544 367.54 -9.35   -2.48%
10/10/18 394.64 396.99 375.61 865,826 376.89 -18.19   -4.60%
10/09/18 397.35 408.87 393.96 536,320 395.08 -3.93   -0.98%
10/08/18 414.17 415.55 388.39 785,224 399.01 -16.70   -4.02%
10/05/18 418.99 430.93 405.48 565,000 415.71 -1.08   -0.26%
10/04/18 424.81 424.97 407.62 587,510 416.79 -9.63   -2.26%
10/03/18 429.59 431.00 418.41 470,167 426.42 -2.75   -0.64%
Download Data To Spreadsheet
Abiomed Inc (ABMD) Stock Rating from Louis Navellier

Navellier Ratings

Powered by Portfolio Grader

Abiomed Inc Stock Analysis

Rating:

Total Grade:

Analysis Breakdown

ABMD Stock Grade:
Fundamental Grade:
Quantitative Grade:
ABMD Earnings
Earnings Growth:
Earnings Momentum:
Earnings Surprises:
Analyst Earnings Revisions:
ABMD Financial Information
Sales Growth:
Operating Margin Growth:
Cash Flow:
Return on Equity:

Abiomed Inc Stock: Weekly View

This Week:
Last Week:
Two Weeks Ago:
Get Full Report